Evidence map›Paper›PMID 42831206›Full record

ArticleJCEM case reports2026

A case of metastasectomy following multiple courses of radionuclide therapy for distant metastatic pheochromocytoma.

Naoki Wada, Satoshi Kawata, Yoshinari Obata, Yoshito Tomimaru, Junji Kozawa, Iichiro Shimomura

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naoki WadaDepartment of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0009-0009-6296-2890
Satoshi KawataDepartment of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0009-0007-2202-175X
Yoshinari ObataDepartment of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0000-0002-3443-3635
Yoshito TomimaruDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0000-0002-4432-060X
Junji KozawaDepartment of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0000-0001-9665-8947
Iichiro ShimomuraDepartment of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka 565-0871, Japan.ORCID https://orcid.org/0000-0002-0851-9603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors derived from chromaffin cells that produce catecholamines. The primary treatment for PPGLs is surgical resection, and even in cases with distant metastases, metastasectomy may be considered. Other therapeutic options for distant metastatic disease include radionuclide therapy, such as

Indexed as

131I-MIBG177Lu-DOTATATEpheochromocytomaradionuclide therapysurgery

Identifiers

PMID42831206
PMCPMC13634677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.